Dexamethasone Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 27 USDMF, 12 CEP/COS, 6 JDMF, 4 EU WC, 7 KDMF, 25 NDC API, 1 VMF, 54 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

691 Drugs in Development

691 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

413 FDF Dossiers, 130 FDA Orange Book, 164 Europe, 25 Canada, 8 Australia, 17 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 0.5MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 1.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 6MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 7 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 3 CD Formulation, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 33 Thickeners and Stabilizers, 28 Direct Compression, 28 Parenteral, 26 Solubilizers, 22 Topical, 21 Granulation, 18 Controlled & Modified Release, 18 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 17 Taste Masking, 12 Rheology Modifiers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 276 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 82 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

69 APIs, 61 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 6 USP, 2 JP, 16 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50065 / DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DEXAMETHASONE(UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)	DEXAMETHASONE	1mg in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	10000[iU] in 1

Inactive Ingredients

Ingredient Name	Major Pharmaceuticals	Preferred Pharmaceuticals Inc.	Preferred Pharmaceuticals, Inc	Fera Pharmaceuticals	Preferred Pharmaceuticals, Inc.	Putney, Inc.
LANOLIN(7EV65EAW6H)
METHYLPARABEN(A2I8C7HI9T)
MINERAL OIL(T5L8T28FGP)
PETROLATUM(4T6H12BN9U)
PROPYLPARABEN(Z8IX2SC1OH)

Setid 8e467d61 E26f 410e B582 465432f087c1 Applno 50065 Form Ointment Ophthalmic Dosage 0 1 Eq 3 5mg Base Gm 10 000 Units Gm - Drug Product Composition: Dexamethasone Acetate